NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -3.1% | 13 | 0.0% | 0.00% | – |
| Q2 2023 | $97 | +7.8% | 13 | 0.0% | 0.00% | – |
| Q1 2023 | $90 | -32.8% | 13 | 0.0% | 0.00% | – |
| Q4 2022 | $134 | – | 13 | -27.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 18 | -70.0% | 0.00% | -100.0% |
| Q2 2022 | $3,000 | +200.0% | 60 | +328.6% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 14 | +133.3% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 6 | -57.1% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | +50.0% | 14 | +40.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -94.1% | 10 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $34,000 | +112.5% | 300 | +100.0% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | -5.9% | 150 | -27.2% | 0.00% | -20.0% |
| Q2 2020 | $17,000 | – | 206 | +312.0% | 0.01% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |